Eosinophil counts as a prognostic marker in glioblastoma: a retrospective cohort study. Giannaris E, Sedor G, Spina CS, Hsieh K, et al. BMC Cancer 2026 May 28. doi: 10.1186/s12885-026-16242.

Read + Share

Amedeo Smart

Independent Medical Education

Giannaris E, Sedor G, Spina CS, Hsieh K, et al. Eosinophil counts as a prognostic marker in glioblastoma: a retrospective cohort study. BMC Cancer 2026 May 28. doi: 10.1186/s12885-026-16242.
PMID: 42210179